老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
ADALTA LTD
0.003
0.000
成交量：
11.62萬
成交額：
349
市值：
963.65萬
市盈率：
-1.30
高：
0.003
開：
0.003
低：
0.003
收：
0.003
52周最高：
0.050
52周最低：
0.003
股本：
32.12億
流通股本：
24.61億
量比：
0.47
換手率：
0.00%
股息：
- -
股息率：
- -
每股收益(TTM):
-0.002
每股收益(LYR):
-0.002
淨資產收益率：
-628.72%
總資產收益率：
-142.26%
市淨率：
26.03
市盈率(LYR):
-1.30
資料載入中...
總覽
公司
新聞資訊
公告
Adalta攜手Oribiotech與Cell Therapies簽署諒解備忘錄 將Iro平台引入澳大利亞及亞太市場
美股速递
·
04/21
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/1AD.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"1AD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AD.AU\",,,,,undefined,":{"symbol":"1AD.AU","market":"AU","secType":"STK","nameCN":"ADALTA LTD","latestPrice":0.003,"timestamp":1789521775826,"preClose":0.003,"halted":0,"volume":116201,"delay":0,"changeRate":0,"nameEN":"ADALTA LTD","floatShares":2461369466,"shares":3212169000,"eps":-0.0023,"marketStatus":"交易中","change":0,"latestTime":"09-16 12:54:33 AEST","open":0.003,"high":0.003,"low":0.003,"amount":349,"amplitude":0,"askPrice":0.004,"askSize":11875019,"bidPrice":0.003,"bidSize":43852803,"shortable":3,"etf":0,"ttmEps":-0.0023,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789538400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.003,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":0.474862,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"1AD.AU","preClose":0.003,"auctionPrice":0.003,"auctionVolume":116201,"auctionTime":1789516735611,"referenceTime":1789468203091,"auction":1,"marketStatus":"盘前竞价","timestamp":1789516735611}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AD.AU\",,,,,undefined,":{"symbol":"1AD.AU","floatShares":2461369466,"roa":"-142.26%","roe":"-628.72%","lyrEps":-0.0023,"volumeRatio":0.474862,"shares":3212169000,"dividePrice":0,"high":0.003,"amplitude":0,"preClose":0.003,"low":0.003,"week52Low":0.003,"pbRate":"26.03","psRate":"23.84","week52High":0.05,"institutionHeld":0,"latestPrice":0.003,"committee":0.573821,"eps":-0.0023,"divideRate":0,"volume":116201,"delay":0,"ttmEps":-0.0023,"open":0.003,"prevYearClose":0.003,"prevWeekClose":0.003,"prevMonthClose":0.003,"prevQuarterClose":0.003,"fiveDayClose":0.003,"twentyDayClose":0.003,"sixtyDayClose":0.003,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/1AD.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-12-09","symbol":"1AD.AU","defaultRemindTime":1765234800000,"type":"split","dateTimestamp":1765198800000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"AU","date":"2021-12-17","symbol":"1AD.AU","defaultRemindTime":1639695600000,"type":"split","dateTimestamp":1639659600000,"forFactor":990277,"toFactor":1000000,"ratio":0.990277},{"market":"AU","date":"2020-08-13","symbol":"1AD.AU","defaultRemindTime":1597276800000,"type":"split","dateTimestamp":1597240800000,"forFactor":981818,"toFactor":1000000,"ratio":0.981818}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"1AD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"1AD.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1128114587","title":"Adalta攜手Oribiotech與Cell Therapies簽署諒解備忘錄 將Iro平台引入澳大利亞及亞太市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1128114587","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128114587?lang=zh_tw&edition=fundamental","pubTime":"2026-04-21 07:20","pubTimestamp":1776727255,"startTime":"0","endTime":"0","summary":"澳大利亚生物技术公司Adalta Ltd与合作伙伴Oribiotech、Cell Therapies共同签署了一份具有战略意义的谅解备忘录。该协议旨在将创新的Iro技术平台推广至澳大利亚及亚太地区。\n这一合作标志着三方在细胞治疗领域的深度协同。通过资源整合与技术共享，合作伙伴计划加速Iro平台在亚太市场的商业化进程，为当地医疗健康产业注入新的技术活力。\n此次布局不仅展现了Adalta Ltd在全球生物技术领域的战略眼光，也预示着亚太地区将成为细胞治疗技术发展的重要增长极。合作各方将共同探索该技术在不同医疗场景中的应用潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AD.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}